ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 227 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,684,559 | -32.5% | 1,424,403 | -22.4% | 0.18% | -30.4% |
| Q2 2023 | $43,972,631 | +24.1% | 1,836,018 | -2.5% | 0.25% | +16.6% |
| Q1 2023 | $35,425,883 | +35.8% | 1,882,353 | +14.8% | 0.22% | +22.6% |
| Q4 2022 | $26,095,794 | +46.8% | 1,639,183 | +50.9% | 0.18% | +25.5% |
| Q3 2022 | $17,775,000 | +24.4% | 1,086,502 | +84.2% | 0.14% | +46.9% |
| Q1 2022 | $14,283,000 | +13.1% | 589,726 | +9.0% | 0.10% | +12.9% |
| Q4 2021 | $12,628,000 | +49.0% | 541,062 | +6.0% | 0.08% | +49.1% |
| Q3 2021 | $8,475,000 | +1643.8% | 510,228 | +2607.5% | 0.06% | +1325.0% |
| Q1 2021 | $486,000 | – | 18,845 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |